ArticleThe Journal of antimicrobial chemotherapy2025

SCY-247, a novel second-generation triterpenoid antifungal, demonstrates high in vitro activity against genetically diverse Candida auris isolates, including FKS1 mutants.

Bram Spruijtenburg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.